MaquiBright® Standardised maqui berry extract, branded, patented*, and safe (GRAS).
MaquiBright® - superior ingredient for the maintenance of hydrated eyes
MaquiBright® is a unique extract prepared from selected maqui berries (Aristotelia chilensis) providing rich purified flavonoids and is standardised to bear a minimum of 25% delphinidins and a minimum of 35% total anthocyanins.
MaquiBright® shows clinically proven bioavailability of key active ingredients.
- supports eye health
- improves tear fluid production
- quenches bothersome discomforts like irritation, blurred vision, sensitivity to light and more
2ND FOSHU HEALTH CLAIM:
Since this product contains delphinidin-3,5-diglucoside, it has the function of relieving eye fatigue and the stiff shoulders caused by viewing the screen of a computer or smartphone for a long time, the function of maintaining the moisture of eyes, and the function of relieving the temporary discomfort of eyes. (translated from Japanese) **
U.S. STRUCTURE/FUNCTION CLAIMS:
MaquiBright® naturally and safely supports eye health with its high antioxidant and anthocyanin content.***
Helps to nourish the eyes and naturally restores the normal production of tears.***
Potent antioxidant that helps to support the eyes’ response to oxidative stress.***
* Issued or pending patents derived from WO2014098092A1 are licensed from Oryza Oil & Fat Chemical Co., Ltd., Japan
** Authorised by Japanese Authority
*** These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
|Dry eye symptoms||MaquiBright® restores tear fluid generation in people with dry eye symptoms.||Hitoe et al., 2014
|MaquiBright® delphinidins quench oxidative stress and hence restore healthy tear fluid production.||Nakamura et al., 2014|
|MaquiBright® supresses photoreceptor cell death by inhibiting production of reactive oxygen species.||Tanaka et al., 2013|
|MaquiBright® significantly enhances tear fluid production and relieves dry-eye related symptoms.||Yamashita et al., 2018|